Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Brolitene
2. Lcb 29
3. N-(2-hydroxyethyl)cinnamide
4. Srilane
1. N-(2-hydroxyethyl)cinnamamide
2. 6961-46-2
3. Brolitene
4. Srilane
5. Lcb 29
6. 2-propenamide, N-(2-hydroxyethyl)-3-phenyl-
7. 35241-61-3
8. (e)-n-(2-hydroxyethyl)-3-phenylprop-2-enamide
9. N-(hydroxy-2 Ethyl)cinnamamide
10. Cinnamamide, N-(2-hydroxyethyl)-
11. Nsc-44979
12. Nsc-58207
13. Nsc-63229
14. N-(2-hydroxyethyl)cinnamide
15. 6c816lub1o
16. (2e)-n-(2-hydroxyethyl)-3-phenylprop-2-enamide
17. Idrocilamide (inn)
18. Ncgc00164510-01
19. Ncgc00164510-02
20. N-(2-hydroxyethyl)-3-phenyl-2-propenamide
21. Idrocilamide [inn]
22. Wln: Q2mv1u1r
23. Dsstox_cid_26404
24. Dsstox_rid_81584
25. Dsstox_gsid_46404
26. Idrocilamidum [inn-latin]
27. (2e)-n-(2-hydroxyethyl)-3-phenylprop-2-enamide, E
28. Idrocilamida
29. Idrocilamidum
30. Idrocilamide [inn:dcf]
31. Idrocilamida [inn-spanish]
32. Cas-6961-46-2
33. Lcb. 29
34. (e)-n-(2-hydroxyethyl)cinnamamid
35. Einecs 230-155-1
36. Nsc 44979
37. Nsc 58207
38. Nsc 63229
39. Unii-6c816lub1o
40. N-(hydroxy-2 Ethyl)cinnamamide [french]
41. Srilane (tn)
42. (z)-n-(2-hydroxyethyl)-3-phenylacrylamide
43. Idrocilamide [mi]
44. Idrocilamide [mart.]
45. Idrocilamide [who-dd]
46. Chembl102358
47. Lcb-29
48. Schembl1171234
49. Schembl1171237
50. Schembl8090977
51. Chebi:134842
52. Hms1580p20
53. Ex-a1480
54. Nsc44979
55. Nsc58207
56. Nsc63229
57. Zinc1677143
58. Tox21_112145
59. Stk429148
60. Akos003239171
61. Akos025149236
62. Tox21_112145_1
63. Db13297
64. N-(2-hydroxyethyl)-3-phenylprop-2-enamide
65. (2e)-n-(2-hydroxyethyl)-3-phenylacrylamide
66. C13775
67. D08063
68. 961i462
69. A846450
70. W-104614
Molecular Weight | 191.23 g/mol |
---|---|
Molecular Formula | C11H13NO2 |
XLogP3 | 0.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 191.094628657 g/mol |
Monoisotopic Mass | 191.094628657 g/mol |
Topological Polar Surface Area | 49.3 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 196 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
M - Musculo-skeletal system
M02 - Topical products for joint and muscular pain
M02A - Topical products for joint and muscular pain
M02AX - Other topical products for joint and muscular pain
M02AX05 - Idrocilamide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Idrocilamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Idrocilamide, including repackagers and relabelers. The FDA regulates Idrocilamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Idrocilamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Idrocilamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Idrocilamide supplier is an individual or a company that provides Idrocilamide active pharmaceutical ingredient (API) or Idrocilamide finished formulations upon request. The Idrocilamide suppliers may include Idrocilamide API manufacturers, exporters, distributors and traders.
click here to find a list of Idrocilamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Idrocilamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Idrocilamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Idrocilamide GMP manufacturer or Idrocilamide GMP API supplier for your needs.
A Idrocilamide CoA (Certificate of Analysis) is a formal document that attests to Idrocilamide's compliance with Idrocilamide specifications and serves as a tool for batch-level quality control.
Idrocilamide CoA mostly includes findings from lab analyses of a specific batch. For each Idrocilamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Idrocilamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Idrocilamide EP), Idrocilamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Idrocilamide USP).
LOOKING FOR A SUPPLIER?